"Medicare Expands Coverage for Wegovy to Address Obesity and Heart Disease"

Medicare may start covering the weight loss drug Wegovy for beneficiaries with a history of heart disease following the FDA's approval of its cardiovascular benefits. Insurers providing Medicare Part D drug plans have been informed that they could cover the medication for this specific use. The FDA approval was based on a study showing a 20% lower risk of cardiac events for those taking Wegovy. However, the high list prices of these medications may still pose challenges for accessibility, and a Congressional Budget Office analysis suggests that the current prices could cost the federal government more than they would save.